Wearable health tracking for advanced solid tumor treatment
Part of Cancer clinical trials.
This trial studies how using a wearable device and smartphone app can help monitor your health during your first cancer treatment for advanced solid tumors. You will receive a known therapy (not a placebo), and the research team will collect real-world data to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced (stage III or IV) solid tumor cancer that cannot be cured with standard treatments.
- You have not yet received any treatment for metastatic cancer (first-line treatment only).
- You are willing and able to wear a small device and use a smartphone app to track your health.
- You have a mobile device with internet access and an email account.
- You do not have a pacemaker, defibrillator, or similar implanted electronic device.
- You are able to fill out questionnaires about your quality of life, nutrition, and mental health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
This study tests different treatments tailored to your cancer's biology. It aims to find which therapy might work best for you, potentially improving outcomes. You'd receive one of the study drugs, with close monitoring and support.
This Phase 1 trial tests a new drug called IUAb190708 designed to help your immune system fight advanced or recurrent solid cancers. The study will evaluate its safety, how your body handles it, and whether it works against your tumor.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This study looks at whether a simple blood test (ctDNA) can tell if your current hormone therapy is starting to stop working, and whether switching to a different hormone therapy early would be better. It aims to keep your cancer under control longer with fewer side effects.
This trial is testing whether a new drug called CT7439 can help people with advanced solid tumors that have not responded to other treatments. It is a phase 1/2 study that also checks the drug's safety and how well it works.
Hear when a new Metastatic Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.